HEALTH | Udaipur News | Udaipur Latest News | udaipur local news । Udaipur Updates udaipurkiran.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from udaipurkiran.com Daily Mail and Mail on Sunday newspapers.
Cipla introduces RT-PCR test kit ViraGen in Indian market: All you need to know
ViraGen is Cipla s third offering in the Covid-19 testing segment. Cipla already has partnerships for antibody detection kit and antigen test kits.
Share
Updated: May 25, 2021, 07:59 PM IST
A real-time Covid-19 testing kit, launched last week by drug major Cipla, will be in the market from Tuesday, the company said. The polymerase chain reaction (RT-PCR) test kit is called ViraGen and is manufactured for the country by the company in partnership with Ubio Biotechnology Systems.
ViraGen is Cipla s third offering in the Covid-19 testing segment. Cipla already has partnerships for antibody detection kit and antigen test kits.
Read more about Barometers trade with tiny losses on Business Standard. The benchmark indices continued trading with minor losses in early afternoon trade. At 12:20 IST, the barometer index, the S&P BSE Sensex, fell 29.22 points or 0.06% at 49,873.42. The Nifty 50 index lost 32.55 points or 0.22% at 14,997.60.
Umang Vohra, MD and Global CEO, Cipla, said, "Cipla has been working relentlessly to ensure accessibility to treatments in this fight against COVID-19. Guided by our core purpose of Caring for Life , this partnership will enable us to reach out to more people across the country at a crucial time like now".
Cipla on Thursday announced the commercialisation of a polymerase chain reaction (RT-PCR) test kit ViraGen for COVID-19 in India.
The test kit is in partnership with Ubio Biotechnology Systems. The announcement was made before market hours today, 20 May 2021.
Shares of Cipla were trading 0.66% higher at Rs 910 on BSE.
ViraGen is Cipla s third offering in the Covid-19 testing segment. Cipla already has partnerships for antibody detection kit and antigen test kits.
ViraGen is a real-time detection kit approved by the ICMR (Indian Council of Medical Research) and is based on multiplex PCR technology. It helps to identify and detect SARS CoV-2 N Gene and ORF Lab Gene with the sensitivity of 98.6% and the specificity of 98.8% as compared to a standard ICMR test. The test is designed for the qualitative detection of nucleic acid from SARS-CoV-2 in the upper and lower respiratory specimens from individuals suspected of COVID-19.